<DOC>
	<DOCNO>NCT01543191</DOCNO>
	<brief_summary>The purpose study determine whether PUR118 safe tolerable population subject Cystic Fibrosis .</brief_summary>
	<brief_title>A Safety Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Males nonpregnant , nonlactating healthy female . Age 18 55 year age ( inclusive ) day sign informed consent . Subject BMI 17 great . Subject confirm diagnosis cystic fibrosis document compatible clinical radiographic presentation , definitive accept lab clinical criterion ( e.g. , sweat chloride &gt; 60 mEq/L 2 disease cause CFTR mutation ) OR regularly attend Consultant lead clinic diagnosis Cystic Fibrosis doubt . Subject FEV1 â‰¥ 45 % predict screening . Subject oxygen saturation &gt; 92 % room air determine pulse oximetry screening . Subject nonsmoker exsmoker smoke least six month prior screen . Subject otherwise medically stable without clinically significant abnormal screening result depart usual baseline level health subject CF . Must willing able communicate English participate whole study . Must provide write informed consent . Subject unstable lung disease , define change medical regimen precede 2weeks , significant new find chest radiograph ( pneumothorax , lobar/segmental collapse ) , opinion Investigator , decline pulmonary status within last year consider part usual , chronic progression CF lung disease part baseline health condition subject CF . Subject exacerbation respiratory symptom within past 30 day require initiation new alter respiratory therapy . Subject either upper low respiratory illness within 30 day prior dose day , symptom illness resolve . Subject history lung transplantation . Females child bear potential pregnant , lactate . Females sexually active either surgically sterile willing use acceptable form contraception Clinically significant abnormal biochemistry , haematology urinalysis consistent CF judge Investigator Failure satisfy Investigator fitness participate reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Lung Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Fibrosis</keyword>
</DOC>